← SynDRA
(E,E)-RGFP966
SynDRA canonical compound SYN1839781 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | HDAC1 | HDAC2 | HDAC3 |
| Mechanism of action | HDAC inhibitor |
All known targets
Mechanisms of action (all sources)
- histone deacetylase inhibitor
- HDAC3 INHIBITOR
Cross-references
Synonyms
- RGFP-966
- RGFP966
- (E)-N-(2-amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide
- CHEMBL4078477
- (E)-N-(2-amino-4-fluorophenyl)-3-[1-[(E)-3-phenylprop-2-enyl]pyrazol-4-yl]prop-2-enamide
- RGFP966 Racemate
- GTPL7500
- SCHEMBL12497867
- SCHEMBL12497871
- EX-A229
- CHEBI:131163
- DTXSID801026037
- AMY10860
- BCP08102
- WFC84157
- BDBM50254780
- MFCD26960954
- s7229
- ZINC95616594
- AKOS030526449
- AKOS037647194
- CCG-268194
- NCGC00381560-10
- RGFP966, >=98% (HPLC)
- AC-32738
- AC-35512
- AS-72773
- AS-77803
- SW219401-1
- A13218
- A922278
- J-007305
- Q27088541
- (2E)-N-(2-Amino-4-fluorophenyl)-3-[1-(3-phenyl-2-propen-1-yl)-1H-pyrazol-4-yl]-2-propenamide
- (2E)-N-(2-amino-4-fluorophenyl)-3-[1-(3-phenylprop-2-en-1-yl)-1H-pyrazol-4-yl]prop-2-enamide
- (2E)-N-(2-Amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl]-2-propenamide
- (2E)-N-(2-amino-4-fluorophenyl)-3-{1-[(2E)-3-phenylprop-2-en-1-yl]-1H-pyrazol-4-yl}prop-2-enamide
- (e)-N-(2-amino-4-fluorophenyl)-3-[1-[(e)-3-phenylprop-2-enyl] pyrazol-4-yl]prop-2-enamide
- 2-Propenamide, N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl]-, (2E)-
Look up (E,E)-RGFP966 in the interactive SynDRA portal →